Wang Guohua, Shi Yejie, Jiang Xiaoyan, Leak Rehana K, Hu Xiaoming, Wu Yun, Pu Hongjian, Li Wei-Wei, Tang Bo, Wang Yun, Gao Yanqin, Zheng Ping, Bennett Michael V L, Chen Jun
State Key Laboratory of Medical Neurobiology and Institute of Brain Science, Fudan University, Shanghai 200032, China; Center of Cerebrovascular Disease Research, University of Pittsburgh, Pittsburgh, PA 15213;
Center of Cerebrovascular Disease Research, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education, and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261;
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2853-8. doi: 10.1073/pnas.1501441112. Epub 2015 Feb 17.
Severe traumatic brain injury (TBI) elicits destruction of both gray and white matter, which is exacerbated by secondary proinflammatory responses. Although white matter injury (WMI) is strongly correlated with poor neurological status, the maintenance of white matter integrity is poorly understood, and no current therapies protect both gray and white matter. One candidate approach that may fulfill this role is inhibition of class I/II histone deacetylases (HDACs). Here we demonstrate that the HDAC inhibitor Scriptaid protects white matter up to 35 d after TBI, as shown by reductions in abnormally dephosphorylated neurofilament protein, increases in myelin basic protein, anatomic preservation of myelinated axons, and improved nerve conduction. Furthermore, Scriptaid shifted microglia/macrophage polarization toward the protective M2 phenotype and mitigated inflammation. In primary cocultures of microglia and oligodendrocytes, Scriptaid increased expression of microglial glycogen synthase kinase 3 beta (GSK3β), which phosphorylated and inactivated phosphatase and tensin homologue (PTEN), thereby enhancing phosphatidylinositide 3-kinases (PI3K)/Akt signaling and polarizing microglia toward M2. The increase in GSK3β in microglia and their phenotypic switch to M2 was associated with increased preservation of neighboring oligodendrocytes. These findings are consistent with recent findings that microglial phenotypic switching modulates white matter repair and axonal remyelination and highlight a previously unexplored role for HDAC activity in this process. Furthermore, the functions of GSK3β may be more subtle than previously thought, in that GSK3β can modulate microglial functions via the PTEN/PI3K/Akt signaling pathway and preserve white matter homeostasis. Thus, inhibition of HDACs in microglia is a potential future therapy in TBI and other neurological conditions with white matter destruction.
严重创伤性脑损伤(TBI)会导致灰质和白质的破坏,继发性促炎反应会使其加剧。尽管白质损伤(WMI)与不良神经状态密切相关,但对白质完整性的维持却知之甚少,目前尚无疗法能同时保护灰质和白质。一种可能发挥此作用的候选方法是抑制I/II类组蛋白脱乙酰酶(HDACs)。在此,我们证明HDAC抑制剂司可来德在TBI后长达35天内对白质具有保护作用,表现为异常去磷酸化神经丝蛋白减少、髓鞘碱性蛋白增加、有髓轴突的解剖结构得以保留以及神经传导改善。此外,司可来德使小胶质细胞/巨噬细胞极化向具有保护作用的M2表型转变,并减轻炎症。在小胶质细胞和少突胶质细胞的原代共培养中,司可来德增加了小胶质细胞糖原合酶激酶3β(GSK3β)的表达,该酶使磷酸酶和张力蛋白同源物(PTEN)磷酸化并使其失活,从而增强磷脂酰肌醇3激酶(PI3K)/Akt信号传导,并使小胶质细胞向M2极化。小胶质细胞中GSK3β的增加及其向M2表型的转变与相邻少突胶质细胞的保留增加有关。这些发现与最近的研究结果一致,即小胶质细胞表型转换调节白质修复和轴突髓鞘再生,并突出了HDAC活性在此过程中以前未被探索的作用。此外,GSK3β的功能可能比以前认为的更为微妙,因为GSK3β可以通过PTEN/PI3K/Akt信号通路调节小胶质细胞功能并维持白质稳态。因此,抑制小胶质细胞中的HDACs是TBI和其他伴有白质破坏的神经疾病未来可能的治疗方法。